Loading...

Living Cell Technologies Limited

LCT.AXASX
Healthcare
Biotechnology
A$0.01
A$0.001(7.14%)

Living Cell Technologies Limited (LCT.AX) Company Profile & Overview

Explore Living Cell Technologies Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Living Cell Technologies Limited (LCT.AX) Company Profile & Overview

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.

SectorHealthcare
IndustryBiotechnology
CEODavid Richard Hainsworth

Contact Information

61 3 8689 9997
Tower 2, Sydney, NSW, 2000

Company Facts

IPO DateSep 1, 2004
CountryAU

Frequently Asked Questions

;